Business Information
The group’s principal activities include marketing and distributing pharmaceutical product. The group’s services include clinical trial management, product registration, and market research and pharmaceutical distribution. The products of the group include Propess, Anpo, Misopess and Fentora. In December 2005 the group acquired Beijing Wanwei Pharmaceutical Co., Ltd. The group’s operates through two segments namely pharmaceutical distribution and, sales and marketing fees. The group operates from China. Of the total revenue in the year 2006, pharmaceutical distribution accounted for $24,189,128 and sales and marketing fees$ 69,141.
|
|
Name |
Title
|
Email
|
| Martyn Greenacre | Chmn. | N/A | | Fred Powell | CFO | N/A | | Byron Wang | VP - Sales, Marketing | N/A | | Albert Yeung | Dir. | N/A | | Amy Zhou | Dir. - Human Resources, China | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 24,258 | (6,796) | | 2005 | 4,179 | (5,724)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
